StreetAccount Macro Headlines:
Novo Nordisk initiated outperform at Santander (DKK 246.95, 0.00)
StreetAccount Sector Summary - Healthcare Post-Market
Afternoon Headlines:
FDA publishes Warning Letter sent to Novo Nordisk on 5-Mar-2026 (DKK 251.55, -2.95)
StreetAccount Sector Summary - Healthcare Pre-Market
StreetAccount Themes Synopsis - ESG - Anthropic challenges Pentagon blacklisting; US states pursue Live Nation antitrust claims
TD Cowen downgrades NOVO.B.DC, NVO
FactSet Podcast - Evening Market Recap, 9-Mar
Powered by FactSet Research Systems Inc.